Goodwin advised Renesas Electronics Corporation on the acquisition of Transphorm, assisted by Wilson Sonsini Goodrich & Rosati. On January 11, 2024, Renesas Electronics Corporation (Renesas, TSE:...
Renesas’ $339 Million Acquisition of Transphorm
Merck’s $680 Million Acquisition of Harpoon Therapeutics
Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted...
Novo Nordisk’s Research Collaborations with Omega Therapeutics and Cellarity
Goodwin advised Flagship Pioneering on the matter. Hogan Lovells acted for Omega Therapeutics, Inc. Novo Nordisk, Omega Therapeutics, Inc. (Nasdaq: OMGA) and Cellarity Inc. announced that Novo Nordisk...
Industrialized Construction Solutions’ Acquisition of Project Frog’s Building Solutions Division
Goodwin advised Project Frog on the sale. Industrialized Construction Solutions Inc. (ICS) announced the acquisition of the Building Solutions Division of Project Frog. Pairing the off-site innovations and...
GreenLight Biosciences Holdings’ Go-Private Transaction
Goodwin Procter advised GreenLight Biosciences, Foley Hoag advised the Special Committee, while O’Melveny & Myers advised Fall Line on the deal. GreenLight Biosciences Holdings, PBC (NASDAQ:...
iLearningEngines’ Merger with Arrowroot Acquisition Corp.
Goodwin advised Arrowroot Acquisition Corp. on the deal. Arrowroot Acquisition Corp. (NASDAQ:ARRW) announced its merger agreement with iLearningEngines. Upon closing of the transaction, the combined company will...
Avadel Pharmaceutics’ $125 Million follow-on Equity Offering
Goodwin Procter advised Avadel Pharmaceutics plc on the deal. Avadel Pharmaceuticals announced an underwritten public offering of 10,000,001 of its ordinary shares, nominal value $0.01 per...